End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | 0.00% | 0.00% | 0.00% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2020 | - | Sales 2021 | 1.49 | Capitalization | 73.82M |
---|---|---|---|---|---|
Net income 2020 | -12M | Net income 2021 | -102M | EV / Sales 2020 * | - |
Net Debt 2020 | 1.41M | Net Debt 2021 | 14.28M | EV / Sales 2021 | 59,246,379 x |
P/E ratio 2020 * |
-
| P/E ratio 2021 |
-0.79
x | Employees | 46 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
6 months | +100.00% |
Managers | Title | Age | Since |
---|---|---|---|
Yakov Kogan
FOU | Founder | 50 | 03-06-04 |
Andrei V. Gudkov
FOU | Founder | 66 | 03-06-04 |
Michael Handley
CEO | Chief Executive Officer | 52 | 21-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
John A. Kallassy
BRD | Director/Board Member | 59 | 22-09-01 |
Uday Saxena
BRD | Director/Board Member | 66 | 22-06-16 |
Michael Handley
CEO | Chief Executive Officer | 52 | 21-07-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-16 | 0.0006 | 0.00% | 26,950 |
24-04-15 | 0.0006 | 0.00% | 931 |
24-04-12 | 0.0006 | 0.00% | 325 |
24-04-11 | 0.0006 | 0.00% | 688 |
24-04-10 | 0.0006 | 0.00% | 2,484 |
End-of-day quote OTC Markets, April 15, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 43.55K | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- STAB Stock